Objective: To study the extent of fetomaternal transfusion and the outcome
of pregnancy after cordocentesis. Material and Methods: 268 women underwent
percutaneous fetal umbilical cord blood sampling for fetal karyotyping bet
ween 15 and 26 gestations of weeks, Complete follow-up was available in 221
(82.5%) of the cases. Cordocentesis was performed under continuous real-ti
me ultrasound guidance. The duration of the procedure and the post-procedur
al bleeding time was counted in seconds. Fetomaternal transfusion was calcu
lated by using the measurements of the maternal serum levels of alpha -feto
protein before and after the procedure. The data were analyzed by Student's
t and multiple regression tests. Results: The maximum and mean amounts of
fetomaternal transfusion were 1.067 and 0.061 ml, respectively. Twenty perc
ent or more alpha -fetoprotein elevation was in 35.4% of the cases. Positiv
e correlation was found between bleeding time after cordocentesis and fetom
aternal transfusion (r = 0.174, p < 0.0129) as well as between the duration
of the procedure (r = 0.165, p < 0.0171) and the amount of fetomaternal tr
ansfusion. Comparing the cordocentesis at the placental insertion site and
at the free cord loop, a smaller amount of fetomaternal transfusion was obs
erved (p < 0.0123) in the latter. Transplacental passage was associated wit
h a higher amount of fetomaternal transfusion (p < 0.0067). No association
was found between the extent of fetomaternal transfusion and the outcome of
pregnancy. The fetal loss related to the cordocentesis was 0.50%. Conclusi
ons: The extent of fetomaternal transfusion was influenced by the subsequen
t four parameters: procedural time, bleeding time, puncture site and transp
lacental penetration. The lack of the association between the degree of fet
omaternal transfusion and the outcome of pregnancy, along with the low (0.5
0%) post-procedural fetal loss rate, suggest that cordocentesis is clinical
ly a safe procedure. Copyright (C) 2001 S. Karger AG, Basel.